| HS Code | 761317 |
| Iupac Name | 5-(Bromomethyl)-4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine |
| Molecular Formula | C17H20BrFN4O2S |
| Appearance | White to off-white solid |
| Solubility | Soluble in DMSO, low solubility in water |
| Smiles | CC(C)c1nc(CBr)c(nc1Nc2ccc(F)cc2)N(C)S(=O)(=O)C |
| Inchi | InChI=1S/C17H20BrFN4O2S/c1-11(2)14-16(10-18)17(22-15(21-14)12-4-6-13(19)7-5-12)23(3)26(24,25)8-9-20/h4-7,11H,8-10H2,1-3H3,(H,21,22) |
| Storage Conditions | Store at 2-8°C, keep container tightly closed |
| Hazard Statements | May cause irritation; harmful if swallowed, inhaled, or in contact with skin |
| Purity | Typically ≥97% (depending on supplier) |
As an accredited 5-(Bromomethyl)-4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100 mg of 5-(Bromomethyl)-4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine supplied in a sealed amber glass vial, labeled with hazard information. |
| Container Loading (20′ FCL) | 20′ FCL (Full Container Load) for this chemical ensures secure, bulk transport, minimizing contamination risks, and maintaining product quality during shipping. |
| Shipping | The chemical **5-(Bromomethyl)-4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine** is shipped in secure, airtight containers compliant with safety regulations. It is transported under controlled temperatures, with appropriate hazard labeling and documentation, ensuring safe handling during transit. Shipping conforms to local and international guidelines for hazardous chemical substances. |
| Storage | 5-(Bromomethyl)-4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine should be stored in a tightly sealed container, away from light, moisture, and incompatible materials such as strong oxidizers. Keep at a cool temperature, ideally 2–8°C (refrigerated). Ensure the storage area is well-ventilated and access is restricted to trained personnel. Use appropriate chemical labeling for safety and regulatory compliance. |
| Shelf Life | Shelf life: Typically 2–3 years when stored in a cool, dry place, protected from light and moisture, and in airtight containers. |
As a direct manufacturer, we supply 5-(Bromomethyl)-4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine to core sectors of chemical synthesis. Our clients deploy this advanced pyrimidine derivative as a structured building block within regulated production pipelines, where strict process specifications and compliance standards apply. The following are key downstream industrial usage scenarios, indicating detailed compliance, ratio, integration, and resulting products for each segment.
Major pharmaceutical corporations utilize this compound as a crucial intermediate during the multi-step synthesis of targeted anticancer molecules, such as kinase inhibitors. Its bromomethyl group allows precise nucleophilic substitution, supporting diversified active pharmaceutical ingredient (API) scaffolds. Synthesis teams favor its stability in high-temperature, anhydrous coupling reactions and documented conversion to active N-heterocyclic structures as characterized by QC and batch release standards.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Global agrochemical producers integrate this pyrimidine derivative into selective herbicide synthesis schemes that target resistant weed species. Its functional groups allow for clean coupling and halogen-exchange reactions, minimizing by-product formation in continuous flow or batch reactors. Synthesis teams appreciate the high assay and low residue profile, which eases downstream purification under production-scale environmental controls.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Manufacturers in the advanced materials sector use this compound in the synthesis of specialty polymer modifiers, especially for high-performance coatings and engineered plastics. Its fluorophenyl and sulfonyl groups equip final polymers with tailored thermal stability and chemical resistance. The raw material’s controlled reactivity supports continuous production of modified monomers, which feed directly into resin and film extrusion lines.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Producers of laboratory reference standards rely on this compound for tailored synthesis of labeled or high-purity calibration materials. Its defined aromatic and pyrimidine structure allows for predictable modification with stable isotopes or fluorophores, ensuring consistency across analytical batches. Quality control teams validate all stages by NMR, HPLC, and MS in controlled cleanroom environments, using the raw material as a benchmark for traceable purity and reproducibility.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Competitive 5-(Bromomethyl)-4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618005193850 or mail to sales8@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8618005193850
Email: sales8@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
As a chemical manufacturer specializing in complex pyrimidine derivatives, we have observed significant shifts in expectations and requirements from research institutions, pharmaceutical developers, and agrochemical innovators over the years. 5-(Bromomethyl)-4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine has emerged as a strategic intermediate, valued for its unique substitution pattern and reactivity, which open up new synthetic possibilities.
This compound, known by its systematic arrangement of functional groups, answers several challenges faced by chemists who push the boundaries of target-oriented synthesis. We have found its adoption grows where both selective functionalization and structural diversity matter most. The bromomethyl site brings pronounced electrophilicity, inviting further modifications by nucleophiles under mild conditions. Synthetic teams report fewer unwanted by-products and higher conversion rates in stepwise reactions compared with phenylpyrimidines without the bromomethyl handle.
On our production lines, the precision required to assemble the isopropyl substituent at the 6-position, the 4-fluorophenyl group, and the methyl(methylsulfonyl)amino function at the 2-position echoes the increasing demand for step-specific purity. The challenges stem less from availability of raw materials and more from the meticulous sequence control and purification methods. Without strict adherence to optimal crystallization profiles and moisture management, this molecule can see significant quality deviations. Our synthesis avoids broad-spectrum reagents, favoring clean conversions and steady yields over high-throughput shortcuts.
5-(Bromomethyl)-4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine typically crystallizes as a solid with expert-defined consistency in appearance and particle size. Production cycles maintain impurity thresholds aligned to industry research standards. Direct feedback from our clients, especially those working in medicinal chemistry, highlights that micro-level impurity profiles impact downstream reactivity. Even trace levels of regioisomeric impurities can impede later alkylations or aminations.
As a manufacturer, we continue to refine our post-reaction purification—introducing controlled filtration and advanced chromatography where necessary. Laboratories performing iterative synthesis prefer batches that store well and resist hydrolysis. Our packaging systems, originally developed for more sensitive pyrimidines, have extended the shelf-life of this intermediate without requiring additional stabilizers. That addresses demands from high-throughput screening labs and scale-up facilities, which cannot afford downtime due to compound degradation.
Over twenty years in pyrimidine chemistry have shown which substitution patterns unlock significant structure-activity relationships. The 4-fluorophenyl substituent stands out for its effect on biological binding, often improving target engagement for research teams working on kinase inhibitors or crop protection molecules. The bromomethyl group delivers versatility for both C-N and C-C coupling, attracting new exploration in heterocyclic chemistry.
Researchers have brought us dozens of case studies comparing this pyrimidine variant to alternatives with iodo or chloromethyl groups. In nearly every synthesis, the bromomethyl’s reactivity profile provides an improved balance between speed and selectivity. Unwanted side reactions drop off, especially in polar aprotic solvents. These properties become harder to access with more heavily substituted or sterically encumbered analogs.
Many labs will try shortcut routes using commercial bromine sources that introduce residual halides or colored by-products. Years of troubleshooting have taught us the importance of clean trialkylamine base additions, gradual temperature ramps, and careful workups. Our trained technicians monitor critical steps using in-house spectroscopy, isolating only fractions meeting specifications for further processing.
Feedback cycles with our partners have driven changes in our standard batches. Earlier production lots, tested both in-house and by external collaborators, prompted process revalidations after impurity spikes were traced back to a new solvent grade. We pivoted away from aggressive drying agents that left problematic residues. Routine investment in analytical instrumentation helped us double-check each step of the multi-stage synthesis and purification train. Environmental considerations now shape solvent selection as much as process reliability.
Given its reactivity and the challenges in handling sensitive intermediates, our teams designed containment and transfer steps that keep exposure risks low. Regular hazmat reviews and skill refreshers anchor our quality and safety standards. We have learned from the experience of seasoned bench chemists who pointed out batch-by-batch differences in offhand discussions. Listening actively to these front-line observations inevitably improves consistency in the manufactured product.
Contract research organizations and pharmaceutical labs rely on predictable batch profiles for screening programs. A minor impurity or the wrong crystal habit disrupts months of candidate evaluation. While some customers ask for gram-scale material for SAR work, pilot plants often require multi-kilogram batches with the same narrow quality profile. Our experience shows that maintaining single-supplier lots limits variance in project outcomes for end users tackling fast-paced timelines.
In one recent scale-up for a medicinal chemistry partner, switching away from a generic supplier of pyrimidines to our material led to a 30% improvement in coupling efficiency for their late-stage intermediates. The chemists reported reductions in purification time and downstream waste, enabling a pivot to lead optimization far earlier than their previous project timelines predicted. This direct impact grows from shared problem-solving and a willingness to customize reaction mediators or isolations on request.
Agrochemical innovators often pursue analogs with subtle electronic modifications to tune selectivity or resistance profiles. Our pyrimidine offers a template for such exploration, especially where other leaving groups lead to solubility or toxicity challenges. Several collaborators have chosen to explore this scaffold for lead series where traditional halogenated intermediates underperform in biological assays.
Conversations with regulatory consultants make one truth clear—trust in the traceability and reproducibility of intermediates grows only from proven transparency. It’s easy for casual observers to overlook the downstream regulatory implications of inconsistent intermediate quality. Differences in impurity load or uncharacterized minor by-products can spell the difference between seamless process transfer and costly remediation.
Reproducibility crises in pre-clinical research have repeatedly exposed the risks of inconsistent chemical feedstocks. As the original manufacturer, we produce extensive batch and run documentation. These records provide the necessary clarity—tracking lot histories and confirming adherence to process controls, ready for any due diligence review or regulatory audit that may come. Our experience suggests that buyers conducting thorough vendor assessments quickly spot the improvements in documentation and technical support we have put in place in recent years.
Not every pyrimidine delivers the same versatility, so our team invested in a substitution pattern that now draws interest from process chemists seeking alternatives to traditional aromatic building blocks. The combination of a strong nucleofuge in the bromomethyl slot and the electron-withdrawing 4-fluorophenyl group offers synthetic chemists a departure from well-trodden phenylpyrimidines. In our hands, this scaffold accepts alkyl, amine, and aryl nucleophiles under conditions where less activated analogs falter. The isopropyl group pushes the molecule toward a particular biological property space, which early-stage discovery teams have found especially promising.
Customers working in oncology, metabolic, or anti-infective pipelines have relayed positive experiences with this product, citing cleaner reaction profiles and reduced post-synthetic purification demands. We invest heavily in continuous flow optimization to address process bottlenecks and to meet stringent downstream purity requirements that often exceed those of the starting materials themselves. Where some may be content to ship variable material speculatively, our team tracks requests for custom isolations and stability studies, shaping improvements batch by batch.
While traders and resellers limit their role to packaging others' materials, as a direct manufacturer we manage hazards, scale-up protocols, and batch testing with an eye toward both safety and efficiency. The road to reliable specialty pyrimidines runs through in-depth troubleshooting, re-commissioning of synthesis rigs, and quarterly equipment recalibrations. These operational factors rarely feature in the talking points of third-party traders, but our staff lives them every week.
Routine GMP training translates into smoother interactions with pharma clients who audit all suppliers annually. This familiarity with technical due diligence means our technical staff fluently discusses not only batch records, but also the implications of specification drift and the rationale behind any technical improvement. Years of direct manufacturing teaches us that many problems—such as dark impurities or difficult filtrations—only surface fully in the hands of a chemist wrestling with a stubborn sequence. The recipes in literature tell part of the story, but ongoing collaboration fills the knowledge gap that makes a difference to sophisticated clients.
Every compound carries its own set of hazards, and brominated pyrimidines deserve special attention for both storage and handling. Our production layout now features dedicated reaction trains to minimize cross-contamination and dedicated containment for materials that might release halogenated volatiles. Lessons learned from minor near-miss events prompted improvements to catch leaks and increase respiratory protection in the hottest stages of the distillation or drying cycles.
Regular reviews with our environmental, health, and safety (EHS) team have translated into changes in supplier choice, waste management, and staff turnover practices. By insisting on fresh master solutions and up-to-date hazard assessments, downtime drops and batch consistency rises. We track environmental exposures and limit outreach only to trusted logistics routes, especially for temperature-sensitive intermediates like this pyrimidine.
Much of our decision-making flows from unfiltered chemist feedback rather than just compliance targets. One recent client, running hundreds of parallel reactions for a kinase inhibitor project, highlighted how the steadier reactivity of our pyrimidine cut screening cycle times significantly. This allowed for deeper dives into structure-activity relationships within the same quarter, a benefit that spurred new collaborations. Process chemists from other sectors have remarked on the improved shelf stability after package upgrades and the consistent particle morphology, which impacts both weighing accuracy and dispersion in automated systems.
From pilot plant trials, we often hear requests for tighter impurity profiles or alternative crystalline forms. We can switch reactor cleaning protocols or adapt crystallizers quickly because our production is fully in-house and responsive to process feedback. These cycles of improvement only come with hands-on manufacturing and the willingness to iterate as new insights emerge. The resulting difference shows not only in purity data, but also in end-user experience at the bench and in the data produced during pre-clinical screening.
Sustainability requirements now factor into almost every sourcing decision. As operators of our own facility, this pushed us to invest in solvent recovery infrastructure and explore greener substitutions for costly or hazardous reagents. Waste minimization no longer stands apart from process control—instead, both grow together. Many years ago, our waste output from pyrimidine lines would have made downstream treatment difficult. By fine-tuning reaction stoichiometry and switching to in-process material recycling, our footprint has grown much less resource-intensive.
Looking forward, the rise of automated synthesis and high-throughput experimentation puts added pressure on core intermediates to deliver not only purity, but also reproducibility and storage resilience. Specialty chemists now prioritize source traceability and supplier reliability beside headline specifications. Our commitment remains to continuous investment in both staff training and new process technologies—seeing each lot as a culmination of chemistry, engineering, and decades of accumulated experience.
Generic vendors offer lower entry costs, but often sidestep the iterative collaboration and rigorous QA that distinguishes a purpose-made intermediate. Years spent alongside lab and plant chemists showed how minor process tweaks could either improve or sabotage downstream reactions. The absence of binding agents, antistatic powders, or other excipients in our batches preserves full reactivity. Subtle improvements, from drying protocols to impurity analysis, bring out the best in this complex molecule.
While some alternatives sacrifice the bromomethyl group for other halides to lower handling challenges or reduce raw material costs, our team invested in maintaining the full substitution motif. Chemists working on next-generation pharmacophores or off-patent analogues have noted the benefits to both yield and functionalization pathways. Feedback on comparable isopropyl- or methyl- substituted pyrimidines shows the same pattern—our approach makes their synthesis both easier and more predictable.
To those seeking a generic off-the-shelf alternative, many routes remain open. For the specialized applications where easy access, predictable quality, and direct troubleshooting matter, direct-from-manufacturer engagement stands out. The cumulative experience embedded in each batch arises not from specification sheets, but from the hundreds of small decisions made at the bench, reactor, and packing line.
Our development of 5-(Bromomethyl)-4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine rests on decades of collaborative experience, iterative improvements, and direct feedback from exacting users. Every shipping lot tells the story of process innovation, regulatory awareness, and technical collaboration. This molecule serves as a testament to those who see specialty chemistry as a craft—as much about the hands and minds that shape it as the specifications that define it.